Screener
aTyr Pharma ATYR Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| General and administrative | 4,133 | 4,929 | 8,252 | 8,888 |
| Total operating expenses | 10,881 | 20,313 | 22,317 | 36,086 |
| Loss from operations | (10,881) | (20,313) | (22,317) | (36,086) |
| Total other income (expense), net | 571 | 781 | 1,215 | 1,673 |
| Consolidated net loss | (10,310) | (19,532) | (21,102) | (34,413) |
| Net loss attributable to noncontrolling interest in Pangu BioPharma Limited | 1 | 1 | 2 | 2 |
| Net loss attributable to aTyr Pharma, Inc. | $(10,309) | $(19,531) | $(21,100) | $(34,411) |
| Net loss per share, basic and diluted | $(0.11) | $(0.22) | $(0.22) | $(0.39) |
Item 1. Financial Statements
FAQ
- What is aTyr Pharma's other income (expense)?
- aTyr Pharma (ATYR) reported other income (expense) of $571K in Q2 2026.
- How has aTyr Pharma's other income (expense) changed year-over-year?
- aTyr Pharma's other income (expense) decreased by 26.9% year-over-year, from $781K to $571K.
- What is the long-term trend for aTyr Pharma's other income (expense)?
- Over 4 years (2021 to 2025), aTyr Pharma's other income (expense) has grown at a 95.9% compound annual growth rate (CAGR), from $238K to $3.5M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about aTyr Pharma's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude